Literature DB >> 1645792

Biochemical characterization of Epstein-Barr virus nuclear antigen 2A.

F A Grässer1, P Haiss, S Göttel, N Mueller-Lantzsch.   

Abstract

The Epstein-Barr virus nuclear antigen 2A (EBNA-2A) was immunoprecipitated from latently Epstein-Barr virus-infected lymphocytes with a polyclonal serum raised against the EBNA-2A C terminus. The nucleus contained three subfractions of EBNA-2A which could be distinguished by their resistance to salt extraction: (i) a nucleoplasmatic fraction that was solubilized at 50 mM NaCl, (ii) a chromatin-associated fraction extractable at 1.5 M NaCl, and (iii) a nuclear matrix-associated fraction solubilized only by boiling with buffer containing 2% sodium dodecyl sulfate. The three subfractions were phosphorylated; it was demonstrated that the nucleoplasmatic and the chromatin-associated fractions were phosphorylated at serine and threonine residues. The half-life of the EBNA-2A protein was determined by cycloheximide treatment and by pulse-chase experiments and was found to be at least 24 h. The turnover of the phosphate residues bound to the two salt-soluble subfractions was determined to be approximately 6 to 9 h, suggesting a possible role of the phosphorylation in the regulation of the biological activity of EBNA-2A. Dephosphorylation of EBNA-2A resulted in an increased mobility of the protein during sodium dodecyl sulfate-polyacrylamide gel electrophoresis and indicated the presence of differentially phosphorylated subclasses of the protein. Analysis of EBNA-2A by sucrose gradient centrifugation revealed the existence of two subclasses of complexed molecules which exhibited sedimentation coefficients of approximately 13S and 34S.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645792      PMCID: PMC241408     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.

Authors:  J V PULVERTAFT
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

2.  Effect of the EBNA-2 gene on the surface antigen phenotype of transfected EBV-negative B-lymphoma lines.

Authors:  P Aman; M Rowe; C Kai; J Finke; L Rymo; E Klein; G Klein
Journal:  Int J Cancer       Date:  1990-01-15       Impact factor: 7.396

3.  Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites.

Authors:  C H Jones; S D Hayward; D R Rawlins
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Purification and characterization of the Epstein-Barr virus nuclear antigen 2 using monoclonal antipeptide antibodies.

Authors:  J Dillner; V Wendel-Hansen; G Kjellström; B Kallin; A Rosén
Journal:  Int J Cancer       Date:  1988-11-15       Impact factor: 7.396

5.  Characterization of an Epstein-Barr virus nuclear antigen 2 variant (EBNA 2B) by specific sera.

Authors:  M Sauter; N Mueller-Lantzsch
Journal:  Virus Res       Date:  1987-08       Impact factor: 3.303

6.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

Authors:  F Wang; C D Gregory; M Rowe; A B Rickinson; D Wang; M Birkenbach; H Kikutani; T Kishimoto; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Characterization of a latent protein encoded by the large internal repeats and the BamHI Y fragment of the Epstein-Barr virus (EBV) genome.

Authors:  M Sauter; H Boos; F Hirsch; N Mueller-Lantzsch
Journal:  Virology       Date:  1988-10       Impact factor: 3.616

8.  Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.

Authors:  W Hammerschmidt; B Sugden
Journal:  Nature       Date:  1989-08-03       Impact factor: 49.962

9.  Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2.

Authors:  M Billaud; P Busson; D Huang; N Mueller-Lantzch; G Rousselet; O Pavlish; H Wakasugi; J M Seigneurin; T Tursz; G M Lenoir
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

10.  The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma.

Authors:  G M Lenoir; M Vuillaume; C Bonnardel
Journal:  IARC Sci Publ       Date:  1985
View more
  24 in total

1.  Conserved region CR2 of Epstein-Barr virus nuclear antigen leader protein is a multifunctional domain that mediates self-association as well as nuclear localization and nuclear matrix association.

Authors:  Michiko Tanaka; Akihiko Yokoyama; Mie Igarashi; Go Matsuda; Kentaro Kato; Mikiko Kanamori; Kanji Hirai; Yasushi Kawaguchi; Yuji Yamanashi
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association.

Authors:  S Harada; R Yalamanchili; E Kieff
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Epstein-Barr virus nuclear antigen 2 binds via its methylated arginine-glycine repeat to the survival motor neuron protein.

Authors:  Stephanie Barth; Michael Liss; Marc D Voss; Thomas Dobner; Utz Fischer; Gunter Meister; Friedrich A Grässer
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  CKII site in Epstein-Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation.

Authors:  Bogaslaw Kwiatkowski; Szu Yu Jenny Chen; William H Schubach
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter.

Authors:  Wei Yue; Edward Gershburg; Joseph S Pagano
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  cdc2/cyclin B1-dependent phosphorylation of EBNA2 at Ser243 regulates its function in mitosis.

Authors:  Wei Yue; Julia Shackelford; Joseph S Pagano
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

7.  The p38 signaling pathway upregulates expression of the Epstein-Barr virus LMP1 oncogene.

Authors:  Pegah Johansson; Ann Jansson; Ulla Rüetschi; Lars Rymo
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

8.  Asymmetric Arginine dimethylation of Epstein-Barr virus nuclear antigen 2 promotes DNA targeting.

Authors:  Henrik Gross; Stephanie Barth; Richard D Palermo; Alfredo Mamiani; Christine Hennard; Ursula Zimber-Strobl; Michelle J West; Elisabeth Kremmer; Friedrich A Grässer
Journal:  Virology       Date:  2009-12-06       Impact factor: 3.616

9.  Expression of the HIV-1 Nef protein in the baculovirus system: investigation of anti-Nef antibodies response in human sera and subcellular localization of Nef.

Authors:  N Kienzle; M Enders; M Buck; H Siakkou; S Jahn; G Petzold; K E Schneweis; M Bachmann; W E Müller; N Müller-Lantzsch
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

10.  Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1.

Authors:  Siddhesh Aras; Gyanendra Singh; Kenneth Johnston; Timothy Foster; Ashok Aiyar
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.